Cargando…

Repurposing Drugs in Small Animal Oncology

SIMPLE SUMMARY: Repurposing drugs in oncology consists of using off-label drugs that are licensed for various non-oncological medical conditions to treat cancer. Repurposing drugs has the advantage of using drugs that are already commercialized, with known mechanisms of action, proven safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giuliano, Antonio, Horta, Rodrigo S., Vieira, Rafael A. M., Hume, Kelly R., Dobson, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817697/ https://www.ncbi.nlm.nih.gov/pubmed/36611747 http://dx.doi.org/10.3390/ani13010139

Ejemplares similares

Oncology Drug Repurposing for Sepsis Treatment
por: Rumienczyk, Izabela, et al.
Publicado: (2022)

The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023)

Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
por: Fu, Leilei, et al.
Publicado: (2022)

Comparative oncology approach to drug repurposing in osteosarcoma
por: Parrales, Alejandro, et al.
Publicado: (2018)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
por: Ioakeim-Skoufa, Ignatios, et al.
Publicado: (2023)

Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022)

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2019)

Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
por: Guerini, Andrea Emanuele, et al.
Publicado: (2019)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
por: Pantziarka, Pan, et al.
Publicado: (2018)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

A Database of Drug Repurposing Clinical Trials in Oncology
por: Pantziarka, Pan, et al.
Publicado: (2021)

Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Small animal oncology /
por: Morris, Joanna, 1964-
Publicado: (2001)

Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma
por: Giuliano, Antonio
Publicado: (2021)

Review of oncological emergencies in small animal patients
por: Tumielewicz, Katrina L., et al.
Publicado: (2019)

In silico approaches for drug repurposing in oncology: Protocol for a scoping review of existing evidence
por: Cavalcante, Bruno Raphael Ribeiro, et al.
Publicado: (2022)

Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
por: Islam, Saiful, et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Small animal clinical oncology
Publicado: (1996)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
por: Dalwadi, Shraddha M., et al.
Publicado: (2023)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
por: Mohi-ud-din, Roohi, et al.
Publicado: (2023)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
por: Rajasegaran, Thiviyadarshini, et al.
Publicado: (2023)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
por: Obermayer, Alyssa N., et al.
Publicado: (2023)

SPIDR: small-molecule peptide-influenced drug repurposing
por: King, Matthew D., et al.
Publicado: (2018)

Identification of repurposed small molecule drugs for chordoma therapy
por: Xia, Menghang, et al.
Publicado: (2013)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
por: Rebelo, Rita, et al.
Publicado: (2021)

Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems
por: Doumat, George, et al.
Publicado: (2023)

Repurposing Drugs to Treat Heart and Brain Illness
por: Cantrell, Maranda S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kmm1ne6mfc7crrlkb4dkbagrk